Sugi Predict

Sugi Predict / Compounds / SCHEMBL563069

SCHEMBL563069

SCHEMBL563069

C=C(C(=O)O)c1ccc(OC)c(OC)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 1/20 0.67
▸ CA1 P00915 1/20 0.67
▸ CA2 P00918 1/20 0.67
▸ CA4 P22748 1/20 0.67
▸ CA6 P23280 1/20 0.67
▸ CA7 P43166 1/20 0.67
▸ TPMT P51580 1/20 0.67
▸ CA9 Q16790 1/20 0.67
▸ CA14 Q9ULX7 1/20 0.67
▸ TSHR P16473 4/20 0.63
▸ CYP1A2 P05177 1/20 0.63
▸ CYP3A4 P08684 1/20 0.63
▸ CYP2C9 P11712 1/20 0.63
▸ CYP2C19 P33261 1/20 0.63
▸ ALDH1A1 P00352 2/20 0.54
▸ GAA P10253 2/20 0.54
▸ ABCG2 Q9UNQ0 3/20 0.54
▸ TNFRSF1A P19438 2/20 0.54
▸ MAPT P10636 5/20 0.53
▸ PDE4A P27815 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30555836 1.00 CA12 (0.67) CA12CA1CA2CA4CA6
SCHEMBL3628967 0.89 TSHR (0.71) CA12CA1CA2CA4CA6
SCHEMBL28568628 0.86 TUBB4A (0.55) CA12CA1CA2CA4CA6
SCHEMBL3291429 0.86 HTT (0.69) CA12CA1CA2CA4CA6
SCHEMBL16867625 0.85 TSHR (0.63) CA12CA1CA2CA4CA6
SCHEMBL27660178 0.85 TSHR (0.50) CA12CA1CA2CA4CA6
SCHEMBL11856961 0.84 KDM4E (0.49) CA12CA1CA2CA4CA6
SCHEMBL11320111 0.84 KMT2A (0.50) CA12CA1CA2CA4CA6
SCHEMBL9066195 0.84 CYP1A2 (0.61) CA12CA1CA2CA4CA6
SCHEMBL28444108 0.84 TSHR (0.61) CA12CA1CA2CA4CA6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118266572-A Application of 3-methoxyphenyl-2-acrylic compound as bitter taste inhibitor 华南理工大学 2024-07-02 — — CN claimed
CN-117264128-A Soft photosensitive polymer material for 3D printing and preparation method thereof 南京大学 2023-12-22 — — CN claimed
CN-116660543-A Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof 中国人民解放军陆军军医大学第一附属医院 2023-08-29 — — CN claimed
US-8859819-B2 Sulphurated derivatives of resorcinol, preparation of same and cosmetic uses thereof PIERRE FABRE DERMO-COSMETIQUE (FR) 2014-10-14 — — US claimed
EP-2417104-A1 SULPHURATED DERIVATIVES OF RESORCINOL, PREPARATION OF SAME AND COSMETIC USES THEREOF Pierre Fabre Dermo-Cosmétique (FR) 2012-02-15 — — EP claimed
US-20120034176-A1 SULPHURATED DERIVATIVES OF RESORCINOL, PREPARATION OF SAME AND COSMETIC USES THEREOF PIERRE FABRE DERMO-COSMETIQUE (FR) 2012-02-09 — — US claimed
WO-2010115945-A1 SULPHURATED DERIVATIVES OF RESORCINOL, PREPARATION OF SAME AND COSMETIC USES THEREOF PIERRE FABRE DERMO-COSMETIQUE (FR) 2010-10-14 — — WO claimed
CN-118266572-A Application of 3-methoxyphenyl-2-acrylic compound as bitter taste inhibitor 华南理工大学 2024-07-02 — — CN disclosed
CN-118266572-A Application of 3-methoxyphenyl-2-acrylic compound as bitter taste inhibitor 华南理工大学 2024-07-02 — — CN disclosed
CN-111587239-B Method for producing lactam compound and lactam compound produced by the method 基础科学研究院 2024-04-02 — — CN disclosed
CN-114957249-A Irreversible covalent CDK inhibitor and preparation method and application thereof 东南大学 2022-08-30 — — CN disclosed
CN-109651253-B Phenylpropanoid ester derivative and application thereof as neuroprotective medicament 上海医药工业研究院 2022-03-25 — — CN disclosed
US-8859819-B2 Sulphurated derivatives of resorcinol, preparation of same and cosmetic uses thereof PIERRE FABRE DERMO-COSMETIQUE (FR) 2014-10-14 — — US disclosed
EP-1697351-A1 2,6-BISHETEROARYL-4-AMINOPYRIMIDINES AS ADENOSINE RECEPTOR ANTAGONISTS Almirall Prodesfarma AG (CH) 2006-09-06 — — EP disclosed
CN-1233629-C Sulfolipid compound with neural nourishing function and synthetic method and application thereof NATURAL PRODUCT CHEMICAL KEY L (CN) 2005-12-28 — — CN disclosed
WO-2005058883-A1 2, 6 BISHETEROARYL-4-AMINOPYRIMIDINES AS ADENOSINE RECEPTOR ANTAGONISTS ALMIRALL PRODESFARMA AG (CH) 2005-06-30 — — WO disclosed
CN-1439632-A Sulfolipid compound with neural nourishing function and synthetic method and application thereof NATURAL PRODUCT CHEMICAL KEY L (CN) 2003-09-03 — — CN disclosed
EP-0394101-B1 Benzothiazepine derivatives, process for their preparation and thereby obtained intermediates, their use as medicines and compositions containing them ROUSSEL UCLAF (FR) 1994-08-24 — — EP disclosed
US-5063225-A Antiarrhythmia ROUSSEL UCLAF (FR) 1991-11-05 — — US disclosed
EP-0394101-A1 Benzothiazepine derivatives, process for their preparation and thereby obtained intermediates, their use as medicines and compositions containing them ROUSSEL-UCLAF (FR) 1990-10-24 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120034176-A1 SULPHURATED DERIVATIVES OF RESORCINOL, PREPARATION OF SAME AND COSMETIC USES THEREOF CBR3, ACSL3, MSRB3 CA12 3727/4885CA1 4774/4885CA2 3387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.